Trial NCT00124748

View at ClinicalTrials.gov 
Aliases: NCT00324636
Org. Study IDs: CSTI571K2301

Last trial update was posted on 2012-02-03

MeSH Interventions

Imatinib Mesylate

MeSH Conditions

Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Leukemia, Myeloid, Chronic-Phase

Other Conditions

Leukemia, Myeloid, Chronic Phase

Stopping Reasons

This study was prematurely discontinued because no improvement was observed in the 800mg dose compared to 400mg dose

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID